Tag Archives: ideas

Investing In Biotech: Tekla CEFs Or IBB?

Summary Biotechnology companies have experienced a sharp selloff, leaving many of them at favorable valuation. Some might consider this a timely opportunity for investing in biotech. One can invest in the biotech sector via passively managed ETFs or actively managed closed-end funds. Here, I compare the CEF alternatives for biotech to IBB. Biotech has been battered recently. Early in the year, there was all that talk of bubbles, which became something of a self-fulfilling prophecy, culminating in a lot of air slowly leaking from the inflated category. Then, the entire market entered its long-predicted, long-awaited correction and biotech dropped along with it. Finally, last Friday, the NY Times and Hillary Clinton piled on, taking issue with excesses by some in the industry, and the category tumbled as the week began. Depending on your view of things, biotech is dead in the water for the foreseeable future and to be avoided, or it’s become horridly oversold and ripe with bargains. If you’re in the first category, you might as well stop here because everything that follows is predicated on the point of view that biotech has generally fallen well below fair price levels. Morningstar’s analytics tend to agree. Here’s its view of the industry as of Sept. 21, which considers the industry to be 14% under fair value: (click to enlarge) It can, of course, go lower, but it hasn’t been this low since 2011. Ok, you’re still reading. Either you agree that biotech is an investable industry or you’re just hanging around to hear more. But, I’m not going to discuss the merits of the industry. That’s been done repeatedly and eloquently by others. DoctoRx is a particularly knowledgeable interpreter of the biotech space; his articles and instablogs are required reading on the topic. What I want to do is explore opportunities for investing in the industry. There are certainly very attractive individual holdings, but my inclination, especially in a volatile and unpredictable area such as this, is to invest broadly using ETFs and CEFs (closed-end funds). That will be the today’s topic. I’ll focus on one ETF and two CEFs. The ETF: iShares NASDAQ Biotechnology ETF (NASDAQ: IBB ) IBB is the standard bearer for biotechnology investors. The fund’s inception date is Feb. 5, 2001. It holds net assets of just over $9B in 145 names. Holdings break down at about 79% Biotechnology, 15% Pharmaceuticals, and 6% in Life- and Bio-Sciences Tools, Services and Supplies. The expense ratio is 0.48%. IBB is indexed to the NASDAQ Biotechnology Index. Components of the index must be listed on the NASDAQ, have a market cap of at least $200M, and trade an average daily volume of at least 100,000 shares. The ETF’s top holdings are: The Closed-End Funds: Tekla Capital Management Two closed-end funds have a longer history in biotechnology. Both are from Tekla Capital Management. Tekla Healthcare Investors (NYSE: HQH ) has an inception date of April 23, 1987. Tekla Life Sciences Investors (NYSE: HQL ) began on May 8, 1992. So, both funds have a long history behind them. The Tekla funds are very similar but have important distinctions. From the Tekla website : “HQH … is broadly based in healthcare. HQL is more focused on life science technology, … expanding the biotechnology focus a bit to include more agricultural biotechnology and environmental technology. Both Funds hold small emerging growth companies, however, given HQL’s technology focus the holdings tend to be somewhat smaller and a little more volatile. The Funds share the same portfolio manager, Daniel R. Omstead, PhD.” HQH has $1.21B in assets under management; HQL has $0.52B. Management fees are 1.13% for HQH and 1.32% for HQL. Top holding for the CEFs are: (click to enlarge) For most closed-end funds, income is a major consideration; HQH and HQL are no exceptions. The funds have a managed distribution policy that distributes 2% of the funds’ net asset values to shareholders quarterly. One can opt to receive the distributions in cash. However, befitting an investment arena that is primarily growth oriented, the default option is for shareholders to reinvest the distributions by receiving them as stock. Not surprisingly, as few of the funds’ holdings pay dividends, distributions are primarily from capital gains. If, however, gains are insufficient to meet the distribution, shareholders are paid return of capital. For both funds, the managers had to resort to return of capital for only two of their quarterly distributions, these for the first two quarters of 2009. Thus, for 28 years [HQH] and 23 years [HQL] have been able to return 8% annually to shareholders from capital gains and income with only 2 misses during the depths of the worst recession since the depression. Currently, HQH is priced at a slight discount (-1.13%) to its NAV and HQL is priced at a slight premium (0.71%). For both, premium/discount levels move up and down regularly. They tend to track each other closely for this metric. (click to enlarge) Performance Total performance for the ETF and the two CEFs over intervals covering up to the past five years is shown below (based on monthly data through Sept. 1, 2015, from Yahoo Finance). (click to enlarge) There is little to differentiate the funds on a performance basis. HQH has not outperformed both of the other two for any of these time spans. HQL has done so, primarily on the basis of its strong performance TTM. HQL’s returns are, as expected, somewhat more volatile. We can see this in this chart of rolling 12-month returns since 2007 (through Sept. 1, 2015). (click to enlarge) The CEFs seem to have deeper troughs, notably through the recession and during early 2014. Premiums and discounts affect the CEFs but not the ETF. The 2014 shortfall is to some large extent a consequence of the funds falling into deep discount valuations. IBB fell well below the CEFs in 2011. I’ve not done a maximum drawdown analysis, but it seems probable that IBB wins on that front but not by a large margin depending on the time frame being considered. HQH has better risk-adjusted returns as shown in this table (data for 3 years from Morningstar). IBB fares least well with its standard deviation indicating a much more volatile fund. HQH, HQL or IBB? It is interesting that there is little to distinguish these three funds on a performance basis over a substantial time scale. From reading the objectives, one might expect more divergence in the performance figures. However, looking at the top holdings, it is clear that, at least for the top ends of the funds’ portfolios, they are fishing in nearly identical ponds. One might be inclined toward the CEFs on those occasions when an investment can be timed to catch a deep discount. An entry at a -6% to -8% discount can cushion downside movements as they occur. And, as we see in the premium/discount charts above, those discounts have consistently returned to premiums over time. On the other hand, I would tend to avoid an entry into either HQH or HQL at any appreciable premium valuation in favor of purchasing IBB. One strategy might be to buy HQH or HQL when the discount is highly favorable, hold the CEF until it moves to a premium, then sell and invest the proceeds in IBB, repeating the cycle as appropriate. Income is a factor. For the investor interested in generating income, the CEFs are the clear choice. One could, of course, hold IBB and sell 2% of shares each quarter and likely end up in about the same place. But, to my mind, it is easier to simply have the fund managers do it for you. A strong advantage of HQH and HQL over nearly all other income-generating CEFs is their long record of increasing principal even after providing a payment of 8% on NAV annually. For both funds, market price has more than doubled over 5 years, and that’s after paying out 2% on NAV each quarter. This puts them at the very top of all closed-end funds. To illustrate how the funds would have rewarded an income investor, I present this chart showing total return (distributions reinvested) and price return (distributions taken as cash) for IBB, HQH, HQL and two equity-income CEFs from Eaton Vance. One is an unleveraged option-income fund (NYSE: ETV ); the other is a leveraged global equity fund (NYSE: ETG ). These may not be the best performers, but neither has been a laggard and, taken together, I think they are reasonably, albeit arbitrary, representatives of equity CEFs. (click to enlarge) The red-orange line shows growth of the fund with income withdrawn. HQH grew 160% while providing 8% cash to its investors annually. HQL grew 170% with the same cash yield. ETV and ETG generated higher distribution yields, but did so with essentially no growth of capital over the five years. For the investor focused primarily on growth, either of the CEFs has provided returns to IBB when held with the default option of taking the distributions as shares (blue lines). In closing, I’ll mention that there are other ETFs available to the biotech investor. I’ll be following up with a survey of those alternatives.

FXU: This Utility ETF Is Different From Your Passive Index Funds

Summary FXU has a high expense ratio, high turnover, and limited exposure to individual companies. The ETF includes some companies that I would not immediately think of as traditional utility allocations. Allocations to FXU can reduce portfolio volatility. The strong dividend yield makes it a viable long term holding if investors are convinced management can justify the high expense ratio with superior returns. Investors should be seeking to improve their risk adjusted returns. I’m a big fan of using ETFs to achieve the risk adjusted returns relative to the portfolios that a normal investor can generate for themselves after trading costs. One of the funds that I’m considering is the First Trust Utilities AlphaDEX ETF (NYSEARCA: FXU ). I’ll be performing a substantial portion of my analysis along the lines of modern portfolio theory, so my goal is to find ways to minimize costs while achieving diversification to reduce my risk level. Expense Ratio The expense ratio on FXU is a hefty .70%, so management needs to be able to beat the sector by a healthy margin over time to provide superior returns to investors relative to lower cost options like the Vanguard Utilities ETF (NYSEARCA: VPU ) which has an expense ratio of only .12%. Holdings I was able to grab a fairly huge chart of the holdings within FXG: (click to enlarge) The first thing I notice in looking at the portfolio allocations is that they are definitely deviating from the indexes I am used to seeing for utility exposure. For instance, Duke Energy Corporation (NYSE: DUK ) is usually one of the largest holdings. VPU uses as the top holding with 7.6% of the portfolio, but FXU has opted to only allocation 3.22% of the portfolio. When it comes to assessing which companies are utilities, I don’t usually think of CenturyLink (NYSE: CTL ) as one of the first options. I would expect it to be in the telecommunications index, but it is interesting to see such a strong allocation here. The interesting thing to note about this portfolio is that it does not use any very heavy weights. I like that aspect of the diversification within the portfolio. When I see a portfolio with extremely concentrated holdings and a high expense ratio, I figure it would make more sense to duplicate the portfolio. Of course, with a high portfolio turnover that is not a viable option. The trailing turnover ratio was around 83%. When investors are paying an expense ratio of .70%, they should be expecting very active management it looks like FXU is certainly delivering in that regard. Building the Portfolio This hypothetical portfolio has a moderately aggressive allocation for the middle aged investor. Only 25% of the total portfolio value is placed in bonds and a fifth of that bond allocation is given to high yield bonds. If the investor wants to treat an investment in an mREIT index as an investment in the underlying bonds that the individual mREITs hold, then the total bond allocation would be 35%. Given how substantially mREITs can deviate from book value, I’d rather consider the allocation as an equity position designed to create a very high yield. This portfolio is probably taking on more risk than would be appropriate for many retiring investors since a major recession could still hit this pretty hard. If the investor wanted to modify the portfolio to be more appropriate for retirement, the first place to start would be increasing the bond exposure at the cost of equity. However, the diversification within the portfolio is fairly solid. Long term treasuries work nicely with major market indexes and I’ve designed this hypothetical portfolio without putting in the allocation I normally would for equity REITs. An allocation is created for the mortgage REITs, which can offer some fairly nice diversification relative to the rest of the portfolio and they are a major source of yield in this hypothetical portfolio. The portfolio assumes frequent rebalancing which would be a problem for short term trading outside of tax advantaged accounts unless the investor was going to rebalance by adding to their positions on a regular basis and allocating the majority of the capital towards whichever portions of the portfolio had been underperforming recently. Because a substantial portion of the yield from this portfolio comes from REITs and interest, I would favor this portfolio as a tax exempt strategy even if the investor was frequently rebalancing by adding new capital. The portfolio allocations can be seen below along with the dividend yields from each investment. Name Ticker Portfolio Weight Yield SPDR S&P 500 Trust ETF SPY 35.00% 2.06% Consumer Discretionary Select Sector SPDR ETF XLY 10.00% 1.36% First Trust Consumer Staples AlphaDEX ETF FXG 10.00% 1.60% Vanguard FTSE Emerging Markets ETF VWO 5.00% 3.17% First Trust Utilities AlphaDEX ETF FXU 5.00% 3.77% SPDR Barclays Capital Short Term High Yield Bond ETF SJNK 5.00% 5.45% PowerShares 1-30 Laddered Treasury Portfolio ETF PLW 20.00% 2.22% iShares Mortgage Real Estate Capped ETF REM 10.00% 14.45% Portfolio 100.00% 3.53% The next chart shows the annualized volatility and beta of the portfolio since April of 2012. (click to enlarge) A quick rundown of the portfolio Using SJNK offers investors better yields from using short term exposure to credit sensitive debt. The yield on this is fairly nice and due to the short duration of the securities the volatility isn’t too bad. PLW on the other hand does have some material volatility, but a negative correlation to other investments allows it to reduce the total risk of the portfolio. FXG is used to make the portfolio overweight on consumer staples with a goal of providing more stability to the equity portion of the portfolio. FXU is used to create a small utility allocation for the portfolio to give it a higher dividend yield and help it produce more income. I find the utility sector often has some desirable risk characteristics that make it worth at least considering for an overweight representation in a portfolio. VWO is simply there to provide more diversification from being an international equity portfolio. While giving investors exposure to emerging markets, it is also offering a very solid dividend yield that enhances the overall income level from the portfolio. XLY offers investors higher expected returns in a solid economy at the cost of higher risk. Using it as more than a small weighting would result in too much risk for the portfolio, but as a small weighting the diversification it offers relative to the core holding of SPY is eliminating most of the additional risk. REM is primarily there to offer a substantial increase in the dividend yield which is otherwise not very strong. The mREIT sector can be subject to some pretty harsh movements and dividends from mREITs should not be the core source of income for an investor. However, they can be used to enhance the level of dividend income while investors wait for their other equity investments to increase dividends over the coming decades. If you want a really quick version to refer back to, I put together the following chart that really simplifies the role of each investment: Name Ticker Role in Portfolio SPDR S&P 500 Trust ETF SPY Core of Portfolio Consumer Discretionary Select Sector SPDR ETF XLY Enhance Expected Returned First Trust Consumer Staples AlphaDEX ETF FXG Reduce Beta of Portfolio Vanguard FTSE Emerging Markets ETF VWO Exposure to Foreign Markets First Trust Utilities AlphaDEX ETF FXU Enhance Dividends, Lower Portfolio Risk SPDR Barclays Capital Short Term High Yield Bond ETF SJNK Low Volatility with over 5% Yield PowerShares 1-30 Laddered Treasury Portfolio ETF PLW Negative Beta Reduces Portfolio Risk iShares Mortgage Real Estate Capped ETF REM Enhance Current Income Risk Contribution The risk contribution category demonstrates the amount of the portfolio’s volatility that can be attributed to that position. Despite TLT being fairly volatile and tying SPY for the second highest volatility in the portfolio, it actually produces a negative risk contribution because it has a negative correlation with most of the portfolio. It is important to recognize that the “risk” on an investment needs to be considered in the context of the entire portfolio. To make it easier to analyze how risky each holding would be in the context of the portfolio, I have most of these holdings weighted at a simple 10%. Because of TLT’s heavy negative correlation, it receives a weighting of 20% and as the core of the portfolio SPY was weighted as 50%. Correlation The chart below shows the correlation of each ETF with each other ETF in the portfolio. Blue boxes indicate positive correlations and tan box indicate negative correlations. Generally speaking lower levels of correlation are highly desirable and high levels of correlation substantially reduce the benefits from diversification. (click to enlarge) Conclusion FXU is an interesting ETF. The exposure is quite materially different from that of the more passive indexes and the individual weightings are lower but the expense ratio is also substantially higher. The fund is considered a utility fund, but they are not afraid to use a small part of the portfolio to go outside of the more traditional utility allocations. Despite a very high turnover ratio, the ETF is still offering a very solid dividend yield. If investors want active management of the allocations within the ETF, FXU is a reasonable allocation. Personally, I have a preference for taking the lower expense ratio and the more passive indexing approach for my long term allocations. Make no mistake; FXU is not a short term allocation. A heavy dividend yield around 3.7% is enough to ensure investors are receiving income from their investment so they can reasonably hold the shares over the long term and utilize the income from dividends for either growing the position or covering living expenses. From a portfolio perspective the ETF is offering a fairly nice low beta of .67 and has maintained a negative correlation with treasury ETFs despite both being influenced by movements in interest rates.

XLE: Energy Stocks Still Overvalued Relative To The Oil Price

Oil may find a bottom this fall at $35-$40 — but that doesn’t mean oil stocks will find a bottom. The XLE energy stock ETF remains highly inflated, as compared with the oil price. Oil and the broader stock market have been trading together since volatility spiked in August. If the S&P 500 goes down another leg to the 1680 range this fall, XLE will fall even farther than the S&P and the oil price will. Don’t buy oil stocks yet — in fact, consider shorting XLE. Ever since the oil price crashed in the fall of 2014, investors have been trying to call a bottom and find an opportunity to invest in the energy sector at bargain values. But so far, the market has frustrated would-be value investors in energy, as the oil price and energy stocks of all types have continued to fall farther and farther. The low to date was reached in the market selloff of August 24-25, when WTIC oil settled at $38.22 and the Energy Select Sector SPDR ETF (NYSEARCA: XLE ) fell to $59.22. Some investors are now hopeful that these prices were the bottom that they have been waiting for, and they think now is finally the time to buy energy stocks and make big profits on the oil price rebound in the coming years. I believe they are half right, but unfortunately it is not the most profitable half. The oil price itself was probably very close to the bottom when it fell into the $37-$40 range for a few days, below $40 for the first time since February 2009. But the large-cap and mid-cap energy stocks in XLE probably have a lot farther to fall. XLE was in the low $40s in February 2009, and it could fall another 33% from its current price before it reaches that level again. The point is that large-cap and mid-cap energy stock prices are influenced both by the oil price and by the performance of the broader stock market in general. Their prices were very low in February 2009 because the oil price and all stock prices were very low. Their prices held up relatively quite well from fall 2014 through spring 2015 because the whole stock market was holding up well then. Investors had confidence that the big oil companies would ride out the oil price drop and continue to prosper along with the entire economy when oil prices recovered. But since the return of volatility in all markets since August, oil stocks no longer have the assurance of the broader market to fall back on. Stocks have dropped decisively from their highs earlier in 2015, and the technical charts point to further declines coming this fall, which of course is a historically weak seasonal period for stocks. Numerous technical indicators signal that if the S&P 500 cannot hold support in the 1820-1867 range, a drop all the way to 1680 is the next likely step down. Moreover, in the current period of volatility, stocks and oil are trading together. When one goes down, so does the other. A bearish market trend and linkage of stocks and oil is very, very bad news for the energy stocks in XLE. One chart shows clearly how much more room XLE has to fall: (click to enlarge) This chart shows the ratio of the share price of XLE to the actual price of WTIC oil, over the entire history of XLE as an ETF, from 1999 to the present. Notice how elevated the XLE price remains today, as compared with the oil price. The ratio has retreated from its all-time highs earlier this year, but it still remains very high compared to most of the past decade and a half. If the broader stock market takes another turn for the worse, this charts shows that XLE has plenty of room to fall along with it, even after the oil price itself nears a bottom and stops falling so steeply. Notice in the chart that until last year, the XLE:$WTIC ratio normally stayed in a range from 0.6 to 0.8. With all stocks in a downward trend, there is no particular reason to expect that XLE will stay elevated above that range, and every reason to expect the likelihood of XLE returning to that range. For example, if the oil price settles at $40 and the XLE:WTIC ratio even returns to the top of the old range at 0.8, that would mean an XLE share price of $32, almost a 50% drop from its current price. If the oil price settles at $35 and the ratio falls to the bottom of the old range at 0.6, that would mean an XLE share price of $21, a 66% drop from its current price. I am not predicting that XLE will crash to $21 or even $32 this fall. I am just pointing out that it is well within the realm of reasonable possibility and would not represent an extreme change in the historical performance of XLE relative to the oil price. More likely is a decline to the low $40s or high $30s this fall, the range that XLE fell to in the crash of 2008-2009. The overall stock market would not have to crash 2008-style for XLE energy stocks to fall to those levels. The process will look very different because in 2008, stocks crashed first and then the oil price dropped, whereas this time the oil price dropped first and stocks are falling later. Actions to take: First of all, don’t buy oil stocks yet! The knife is still falling. More aggressive investors can consider shorting XLE. As a hedge, investors can short XLE and buy The United States Oil ETF, LP ( USO) to play a decline in the XLE:$WTIC ratio.